Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Uterine Cervical Neoplasms 2Ovarian Neoplasms 2Neoplasm Metastasis 2Multiple Myeloma 2Lymphoma 2Leukemia, Myeloid, Acute 2Hematologic Neoplasms 2Glioblastoma 2Carcinoma, Renal Cell 2Advanced Malignant Solid Neoplasm 2Vaginal Neoplasms 1Uterine Neoplasms 1Urinary Bladder Neoplasms 1Tongue Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumors 1Rhabdomyosarcoma 1Rectal Neoplasms 1Prostatic Neoplasms 1Pinealoma 1Pancreatic Neoplasms 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Neoplasms 1Myelodysplastic Syndromes 1Metastatic Pancreatic Adenocarcinoma 1Meningeal Carcinomatosis 1Melanoma 1

Interventions

fludarabine phosphate 8Cytarabine 8Peripheral Blood Stem Cell Transplantation 7Imatinib Mesylate 5Cyclophosphamide 5Busulfan 5Vorinostat 4Filgrastim 4Etoposide 4Antilymphocyte Serum 4tipifarnib 3sargramostim 3Sorafenib 3Radiotherapy 3Methylprednisolone 3Methotrexate 3Ifosfamide 3Decitabine 3Cyclosporine 3Bortezomib 33-aminopyridine-2-carboxaldehyde thiosemicarbazone 3temsirolimus 2laromustine 2belinostat 2alvocidib 2Vincristine 2Sirolimus 2Mycophenolic Acid 2Interferon-alpha 2Idarubicin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Blast Crisis × adavosertib × Clear all
NCT02381548 2026-01-30

Phase I Trial of AZD1775 and Belinostat in Treating Patients With Relapsed or Refractory Myeloid Malignancies or Untreated Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 1 Terminated
20 enrolled
MyeloidOther hematologic neoplasm

Blast Crisis, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡